Finasteride results prostate

Primal Flow® Prostate Formula - Shrinks Enlarged Prostat

All Natural Primal Flow® Shrinks & Normalizes Enlarged Prostate In Just Weeks. Order Now Medikament gegen Haarausfall online anfordern - Fachliche Behandlung durch erfahrene Ärzte. Seit 2011 behandelt ZAVA Patienten europaweit. Hervorragende Bewertung auf Trustpilot Conclusions: In the Prostate Cancer Prevention Trial cohort the adjustment factor required to preserve median PSA increased from 2 at 24 months to 2.5 at 7 years after the initiation of finasteride Finasteride does shrink the prostate and therefore appears to have some benefit. The benefits are most visible for men with prostates larger than 40g, and it offers some symptomatic relief (approximately a 20% improvement over a year) by reducing the size of the prostate

Proscar: Uses, Dosage & Side Effects - Drugs

Results. As compared with the men in the placebo group, the men treated with 5 mg of finasteride per day had a significant decrease in total urinary-symptom scores (P<0.001), an increase of 1.6 ml. In 2003, results from the Prostate Cancer Prevention Trial (PCPT) —an NCI-funded randomized clinical trial with nearly 19,000 participants—showed that men aged 55 and older who used the drug finasteride daily for 7 years had a substantially reduced risk of developing prostate cance Finasteride efficacy was estimated using Cox proportional regression models to generate hazards ratios (HRs). Results and limitations: Mean length of follow-up was 5.3 yr. The rate of clinical BPH was 19 per 1000 person-years in the placebo arm and 11 per 1000 person-years in the finasteride arm (p<0.001) Finasteride works by blocking the conversion of the hormone testosterone to the more potent hormone dihydrotestosterone. It does this by blocking an enzyme called 5-alpha reductase. Dihydrotestosterone is partly responsible for making the prostate enlarge. Therefore, a reduced amount of dihydrotestosterone in the prostate causes it to shrink

The trial was funded by the U.S. National Cancer Institute and enrolled nearly 19,000 men between 1993 and 1997. Initially it found that finasteride -- a hormone -blocking drug -- cut the risk of.. If you are taking this medicine for benign prostatic hyperplasia (BPH), it may take up to 6 months to see the full effect. The medicine will not cure BPH, but it does help reduce the size of the prostate and improve symptoms. The effect on the prostate will only last as long as the medicine is used Finasteride Results. 1997. 166 men, aged 18-40. 1 mg daily. 1 year. 70% saw no additional hair loss, measured by count65% reported slowed hair loss, by self reporting 52% improved by clinician's assessment 37% improved by photographic assessment. 1998. 1553 men, 18-40 years. 1 mg daily

Finasteride, an oral medication that blocks the formation of DHT, has been found to be the most effective therapy for male pattern baldness. But there are things you can do in combination with taking finasteride to maximize results. Studies have found that using finasteride and minoxidil together is more effective than using either one alone Finasteride can cause a decrease in your prostate specific antigen (PSA) level. An increased level of this antigen has been associated with prostate cancer. If your PSA levels increase while on..

Haarwuchsmittel online - Ohne Rezept vora

  1. Finasteride (Propecia) is used to treat male pattern hair loss in men. Finasteride (Proscar) is used to treat symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. finasteride is for use in men only. Finasteride may also be used for purposes not listed in this medication guide
  2. The study found that finasteride reduced the risk of prostate cancer by 25% but was associated with a slight increase in high-grade (more aggressive) disease among men in the finasteride group (6.4%) versus men in the placebo group (5.1%). The absolute increase was only 1.3%
  3. Finasteride tablets are not approved for the prevention of prostate cancer. The use of finasteride tablets increases the risk of developing high-grade prostate cancer in men older than 55 years. May not be suitable for some people such as those with obstructive uropathy
  4. Results and Conclusions. Among men with detectable finasteride concentrations, there was no association between finasteride concentrations and prostate cancer risk, low-grade or high-grade, when finasteride concentration was analyzed as a continuous variable or categorized by cutoff points
  5. This medication works by decreasing the amount of a natural body hormone (DHT) that causes growth of the prostate.Finasteride is not approved for prevention of prostate cancer. It may slightly..
  6. The latest results report mortality over 2 decades among men in the Prostate Cancer Prevention Trial, which previously found that finasteride reduced risk for prostate cancer by 24.8% compared.

Long-term effects of finasteride on prostate specific

  1. Finasteride is safe, inexpensive, and effective as a preventive strategy for prostate cancer, said Ian Thompson, Jr, MD, principal investigator of the PCPT for SWOG. Doctors should share these results with men who get regular prostate-specific antigen tests that screen for the presence of prostate cancer
  2. Finasteride (Proscar) and other 5-alpha-reductase inhibitors (5-ARIs) are most commonly used for the treatment of obstructive urinary symptoms due to enlarged prostate. Despite Level I evidence, the use of finasteride for prostate cancer prevention has not been widely adopted by the medical community
  3. Finasteride reduces total serum prostate specific antigen (PSA). In a typical patient undergoing treatment for BPH with finasteride (>= 6 months), a 50% decrease in serum PSA concentrations can be expected; however, individual patients may experience varying decreases in PSA values
  4. Other long-term studies of finasteride show similar results, with a 1mg dose of finasteride well tolerated over a period of five years. There have been reports of a slight increased risk (1.8% with 5mg Finasteride dosage versus 1.0% Placebo) of High Grade Prostate Cancer for men over age 55 years old
  5. Finasteride can affect the results of PSA testing (a blood test to check for prostate cancer) This medicine gets into semen and can harm an unborn baby. Use a condom when having sex if your partner is pregnant or could get pregnant. If you're pregnant or trying to get pregnant, do not touch crushed or broken finasteride tablets
  6. A potent androgen (male hormone), dihydrotestosterone can promote prostate growth, causing BPH. Finasteride is used to shrink the prostate gland, which helps to reduce symptoms such as increased urination, a weak or interrupted urine stream, painful urination and ejaculation, urinary retention, and incontinence. 2 
  7. Finasteride blocks the action of an enzyme called 5-alpha-reductase. This enzyme changes testosterone to another hormone that causes the prostate to grow or hair loss in males. It will increase testosterone levels in the body, which decreases prostate size and increases hair growth on the scalp. The effect of finasteride on the prostate and.

Using Finasteride to Treat an Enlarged Prostate - Ben's

  1. Finasteride, a common hormone-blocking drug, reduces men's risk of getting prostate cancer without increasing their risk of dying from the disease. Initial study findings suggested there may be a link between use of the drug and a more lethal form of prostate cancer, but long-term follow-up shows that is not true
  2. Four thousand four hundred forty men in the finasteride group of the PCPT underwent prostate biopsy, had at least one PSA and a digital rectal exam (DRE) during the year before biopsy, had at least two PSA values from the 3 years before biopsy, and were on finasteride at the time of PSA evaluation
  3. Learn the results of the Prostate Cancer Prevention Trial, which was a study designed to see whether the drug finasteride (trade name Proscar) could prevent prostate cancer in men ages 55 and older
  4. But when results were analyzed by Gleason grade, men taking finasteride who did develop the disease appeared to be at higher risk for high-grade disease. In the finasteride group, Gleason grade was available for 686 men: 264 (38.5%) had Grade 7 or higher, and 81 (11.8%) had Grade 8 or higher
  5. Finasteride is used to treat men with benign prostatic hyperplasia (BPH) and male pattern hair loss, also called androgenetic alopecia. BPH is caused by an enlarged prostate. Men with BPH usually have difficulty urinating and a need to get up at night to urinate
  6. Erfahren Sie, wie Sie eine vergrößerte Prostata erkennen und was Sie dagegen tun können. PRORED3 ist ein wirksames Produkt für Prostata, Potenz und Vitalität. 1. Monat kostenlos
  7. We previously reported the results of the Prostate Cancer Prevention Trial, in which 18,882 men were randomly assigned to receive finasteride or placebo for 7 years

The Prostate Cancer Prevention Trial has shown a protective effect of finasteride on prostate cancer, but it also showed that finasteride can increase the risk of high-grade prostate cancer. Several studies have investigated the relationship between finasteride and prostate cancer, but these studies have shown inconsistent results The effects of finasteride on PSA have been studied in several cohorts of men with symptomatic BPH.11, 12, 13 Initial results indicated that finasteride causes an average 50% decrease in PSA by 1 year following the initiation of treatment. 11 This 50% decrease also appeared to apply at the individual level, leading to the multiply by 2 rule.

The Effect of Finasteride in Men with Benign Prostatic

Conversation on Prostate Cancer Prevention and Finasteride

What is Finasteride? Finasteride has active ingredients of finasteride. It is often used in prostate examination abnormal. eHealthMe is studying from 30,408 Finasteride users for its effectiveness, alternative drugs and more. What is Enlarged prostate? Enlarged prostate is found to be associated with 1,754 drugs and 1,073 conditions by eHealthMe But when results were analyzed by Gleason grade, men taking finasteride who did develop the disease appeared to be at higher risk for high-grade disease. In the finasteride group, Gleason grade was available for 686 men: 264 (38.5%) had Grade 7 or higher, and 81 (11.8%) had Grade 8 or higher Photo: SWOG/The Hope Foundation EurekAlert.org PORTLAND, OR - Twenty five years after it opened for enrollment, the landmark Prostate Cancer Prevention Trial has delivered a final verdict. Finasteride, a common hormone-blocking drug, reduces mens' risk of getting prostate cancer without increasing their risk of dying from the disease. Initial study findings suggested there may be a link.

Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Neuhouser ML(1), Till C, Kristal A, Goodman P, Hoque A, Platz EA, Hsing AW, Albanes D, Parnes HL, Pollak M Finally, because PSA testing had better performance for identifying men with prostate cancer in the finasteride group, the 24.8% decrease in the 7-year period prevalence of prostate cancer reported among men on the finasteride arm of the PCPT is likely to be an underestimate of the actual reduction in prostate cancer risk with finasteride ( 1) Subjects were randomly assigned for 7 years between placebo and finasteride. At the end of the study, all were biopsied. The study showed that finasteride reduced the detection of confirmed CaP by 25%. As this result was better than anticipated, the study was terminated early and its results reported Finasteride concentrations and prostate cancer risk: Results from the prostate cancer prevention trial. Cindy H. Chau, Douglas K. Price, Cathee Till, Phyllis J. Goodman, Xiaohong Chen,. The results of a 3-month prospective and consecutive study conducted to evaluate the onset of symptom relief in men treated with dutasteride versus finasteride were reported at the 2004 American Urological Association (AUA) meeting. 9 One hundred and twenty men with symptomatic BPH were treated with dutasteride followed by an additional 120 men treated consecutively with finasteride for 3 months

Finasteride reduces the risk of incident clinical benign

Finasteride results in an average reduction of 50% for the prostate specific antigen score (PSA test). The score should be doubled to work out the risk of prostate cancer. The risk of prostate cancer related to finasteride use has been very carefully reviewed. Current evidence is reassuring and it does not seem to increase the risk or cancer. Finasteride prevents low grade prostate cancer but not high grade prostate cancer. So if you have the high grade type, finasteride will shrink the prostate and make it easier to find. So finasteride improves the diagnostic performance of the PSA test and biopsies, prevents low grade PC, and may reduce it or render it undetectable for men on AS The prostate is a gland that routinely gets inflamed. When it does, finasteride can help by preventing the over metabolism of testosterone, which leads to an prostatic hypertrophy. Also used to restore lost hair in people, finasteride is especially helpful in maintaining healthy testosterone levels. Learn more about how this Proscar generic option works here Here is a quote: In 2015, Traish et al [32] reported that long-term finasteride therapy results in worsening of EF and lower total testosterone levels in men with BPH. In their retrospective registry study, a cohort of 470 men aged between 47 and 68 years (mean: 57.78±4.81 years) were treated with finasteride 5 mg

While the study was conducted with the 5 milligram formulation of finasteride (Proscar®), and was concerned only with prostate cancer prevention, the study results raised questions among patients as well as professionals regarding the use of finasteride 1 mg (Propecia®) for treatment of hair loss The effects of finasteride on or dutasteride.4 Finasteride, a 5␣-reductase inhibitor, acts PSA have been studied in several cohorts of men with symp- chemically by blocking dihydrotestosterone production and tomatic BPH.11⫺13 Initial results indicated that finasteride shrinking prostate volume.2, 5 Clinical trials have shown that causes an. mg/day (5 times the dose of PROPECIA) in the 7-year Prostate Cancer Prevention Trial (PCPT) had an increased risk of Gleason score 8-10 prostate cancer (finasteride 1.8% vs placebo 1.1%). [See Adverse Reactions (6.1).] Similar results were observed in a 4-year placebo-controlled clinical trial with another 5α-reductase inhibito

Finasteride is a white crystalline powder with a melting point near 250°C. It is freely soluble in chloroform and in lower alcohol solvents, but is practically insoluble in water.. PROSCAR (finasteride) tablets for oral administration are film-coated tablets that contain 5 mg of finasteride and the following inactive ingredients: hydrous lactose, microcrystalline cellulose, pregelatinized. T1 - Prediction of prostate cancer for patients receiving finasteride. T2 - Results from the prostate cancer prevention trial. AU - Thompson, Ian M. AU - Ankerst, Donna Pauler. AU - Chi, Chen. AU - Goodman, Phyllis J. AU - Tangen, Catherine M. AU - Lippman, Scott M. AU - Lucia, M. Scott. AU - Parnes, Howard L. AU - Coltman, Charles A. PY - 2007. Finasteride is an oral medication used to treat male pattern baldness in men only. It is not for use by women. When used by men, finasteride is generally safe but it can also cause serious side effects, including but not limited to allergic reactions, sexual dysfunction, depression, and high-grade prostate cancer Finasteride (Proscar) is used alone or in combination with another medication (doxazosin [Cardura]) to treat benign prostatic hypertrophy (BPH, enlargement of the prostate gland). Finasteride is used to treat symptoms of BPH such as frequent and difficult urination and may reduce the chance of acute urinary retention (sudden inability to urinate)

PROSCAR (PROPECIA) x 1 TABLETS (5mg) Finesteride Finesterida

Proscar, also called finasteride, is a common drug that reduces the size of the prostate. The new analysis is based on data from more than 21,000 men studied in 23 clinical trials, most of which. Proscar (finasteride) is an inhibitor of steroid Type II 5a-reductase, that works by decreasing the amount of a natural body hormone dihydrotestosterone that causes growth of the prostate, and is used to treat symptoms of benign prostatic hyperplasia in men with an enlarged prostate. Proscar is available in generic form The Food and Drug Administration (FDA) states that finasteride and other 5-alpha reductase inhibitors can cause a 50% reduction in prostate-specific antigen (PSA) levels within 6 months. PSA is a. Finasteride (brand name: Proscar) treats benign prostatic hyperplasia, a condition in which the prostate becomes abnormally enlarged 2 3. Information from the National Library of Medicine describes finasteride as a member of a group of drugs named for the enzyme they target, 5-alpha reductase 1 2 3.By blocking the activity of this particular enzyme, finasteride prevents it from producing.

Dutasteride and finasteride are two popular 5alpha-reductase inhibitors that are used to treat BPH. These drugs prevent male hormones from increasing the size of your prostate. You generally need. Increased Risk of High-Grade Prostate Cancer with 5α-Reductase Inhibitors. Men aged 55 and over with a normal digital rectal examination and PSA ≤3.0 ng/mL at baseline taking finasteride 5 mg/day (5 times the dose of finasteride) in the 7-year Prostate Cancer Prevention Trial (PCPT) had an increased risk of Gleason score 8 to 10 prostate cancer (finasteride 1.8% vs placebo 1.1%) Finasteride is a synthetic 4-azasteroid compound. Finasteride competitively binds to and inhibits steroid type II 5-alpha-reductase in the prostate gland, liver, and skin, thereby interfering with the enzymatic conversion of testosterone to 5-dihydrotestosterone (DHT) and reducing serum DHT levels. The reduction in serum DHT levels results in diminished stimulation of androgen receptors in the.

We also examined whether the effects of finasteride (the PCPT study drug) were modified by alcohol consumption, because both affect the metabolism of testosterone. 24, 25 Results of this study address whether alcohol consumption is associated with risks of biopsy-detected presence or absence of local stage prostate cancer and whether alcohol. The main side effects are losing interest in sex and difficulty getting an erection. Finasteride can affect the results of PSA testing (a blood test to check for prostate cancer) This medicine gets into semen and can harm an unborn baby. Use a condom when having sex if your partner is pregnant or could get pregnant Alcohol consumption, finasteride, and prostate cancer risk Results from the prostate cancer prevention trial. Zhihong Gong PhD, Corresponding Author. Zhihong.gong@ucsf.edu; Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California

Finasteride for prostate gland enlargement

Finasteride is a medication used in dogs to restore infertility issues caused by benign prostatic hypertrophy (an enlargement of the prostate gland caused by hormones) and treat the general clinical signs associated with it. Finasteride comes in pill form and is given orally (by mouth). It may be given with or without food. This short-acting medication should stop working within 24 hours. Rex Cancer Center medical oncologist Dr. Jeffrey Crane will discuss a drug, finasteride, that may help prevent prostate cancer Finasteride results in a decrease of circulating DHT levels by about 65 to 70% with an oral dosage of 5 mg/day and of DHT levels in the prostate gland by up to 80 to 90% with an oral dosage of 1 or 5 mg/day

As previously reported, finasteride does increase the sensitivity of PSA and DRE for detecting cancer, particularly high-grade disease (16, 17), and the results of this study suggest that finasteride decreases prostate volume. Furthermore, selective inhibition of low-grade cancer in men with cancers that contain both low- and high-grade. Showing results for finasteride. Search instead: 5-alpha reductase inhibitors, Antiandrogens. Treatment of androgenetic alopecia in men View in Chinese prostatic hypertrophy. Although finasteride is teratogenic, The initial analysis found a 25 percent decrease in the incidence of prostate cancer with seven years of finasteride,. In the PCPT, the median prostate volume among men in the finasteride group was 25.5 cm 3 versus 33.6 cm 3 in controls (a 24.1% reduction in the treatment arm). The reduction in prostate volume. Interestingly, of the prostate cancer deaths in which tumor grade was known, more than a third of the men who died of prostate cancer were originally diagnosed with a Gleason < 6 tumors, the type of cancer that is reduced significantly with finasteride. The majority of the results of the PCPT are now in. Seven years of treatment with.

Finasteride Can Safely Cut Prostate Cancer Ris

Some feel that the Finasteride makes it easier to detect these higher grade cancers, but it is a risk that should be acknowledged.The PDR does state, Whether the effect of 5α-reductase inhibitors (like Finasteride) to reduce prostate volume, or study-related factors, impacted the results of these studies has not been established Results. Decreases in symptom score, dihydrotestosterone and prostate-specific antigen levels, and pros-tate volume occurred at 6 months (P,0.01), stabilized, and were maintained without further long-term decreases. Prostate epithelium contracted progressively from baseline (19.2% tissue composition; 6.0-c Results. In subjects with no cancer in the end of study biopsy PSA in the finasteride arm showed a median annual decrease of 5% after year 1, while PSA in the control arm showed an annual increase of 3% (p <0.001). In end of study cases PSA increased annually by 6% (placebo) and 7% (finasteride)

Contemporary Prostate Cancer Prevention (Slides with

The results suggest that though finasteride lowers DHT levels, the net effect of hormones acting on the prostate may be unchanged by the drug, according to Ross Finasteride taken for 7 years in the Prostate Cancer Prevention Trial (PCPT) reduced the risk of prostate cancer by 25%, but with an apparent increased risk of high-grade disease. Subsequent analyses found that finasteride biases toward improved prostate cancer detection and accuracy in prostate cancer grading at biopsy. In our first analysis of the present study, we accounted for these biases. Overall ratings: 3.3/5. Long term ratings: 3.4/5. This is a phase IV clinical study of how effective Finasteride (finasteride) is for Prostate and for what kind of people. The study is created by eHealthMe from 15 Finasteride users and is updated continuously

Finasteride (Oral Route) Proper Use - Mayo Clini

Finasteride use results in a significantly lower risk of prostate cancer (PCa) long after the medication is discontinued, researchers concluded. The finding extends the results of the Prostate. In men aged 40-60 years, 1 mg/day finasteride for 48 weeks lowers serum PSA concentration. Therefore, the existing recommendation for the adjustment of serum PSA concentration in prostate-cancer screening in men taking 5 mg/day finasteride should also apply to men taking the 1 mg/day preparation for male-pattern hair loss. Research is needed to assess the effect of 1 mg/day finasteride. Finasteride, a 5 alpha reductase inhibitor, is an established treatment for benign prostatic hyperplasia. The recommended dosage is 5 mg a day, however case reports have show effectiveness with lower doses. The objective of the current study was to determine in men with benign prostatic hyperplasia, previously treated for at least one year with finasteride 5 mg daily, if they will maintain. It takes time for finasteride to take effect. First, it reduces the DHT in your scalp, which is suffocating the hair follicles so you need to take it on faith, or the many success stories (like me) and on reddit. You should start seeing results in 3 months, although you should keep taking it for 9-12 months and see what the results are then

Prostate cancer is highly unusual in men under the age of 50, so I routinely get a PSA test on all men over 50 who I start on Propecia/finasteride. The interesting studies indicate that this drug will reduce the risk of prostate cancer, and that is great news If finasteride can shrink the size of a man's prostate, and it is a very safe drug (which it certainly is), then maybe it can be tested as a drug to prevent the onset of prostate cancer! The early trial results were promising, and in 1992 Merck partnered with the National Cancer Institute to develop and implement the Prostate Cancer. Dr. Raghavan said he is less inclined to believe that finasteride is altering the biology of the cancer and more inclined to think that finasteride may be reducing the prostate, making it easier to see the cancer foci. Two recent analyses of the PCPT results came to a similar conclusion (J Natl Cancer Inst 99:1366-1374; 1375-1383, 2007) The results of an 18-year, 18,000 patient study on prostate cancer prevention, published in August 2013 in the New England Journal of Medicine, showed that taking finasteride 5mg a day does not increase the likelihood of death from prostate cancer. Early results from the same study had suggested that finasteride might increase the risk of. Study results should be explained to men being treated for BPH with dutasteride or finasteride, as these prostate drugs increase diabetes risk according to researchers. Results from a new study led by the University of Edinburgh and UCL suggests men taking medicines to reduce the symptoms of prostate disease may be more likely to develop type 2.

Finasteride Results: How Well Does Fin Work for Men's Hair

The results showed that finasteride increased the number of high-grade prostate cancers—a finding that resulted in a drug label warning posted by the U.S. Food and Drug Administration. That. Proscar (finasteride) can lower prostate-specific antigen levels (PSA) in your body, which may affect the results of a prostate cancer test. Your doctor should test your PSA levels at least 6 months after starting treatment to get a new baseline level for you, and watch closely thereafter. PROSTATE CANCER. Risk factors: Men aged 55 and ove

Does Propecia or Finasteride Work? - QuoraPropecia for Hair Loss - Dr Rogers, New Orleans, LALong-Term Effects of Finasteride on Prostate CancerUncover The Best Prostate Pills And Where To Buy Them[Full text] Combination of tadalafil and finasteride for

have not been taking PROPECIA as prescribed because this may affect the PSA test results. For There may be an increased risk of a more serious form of prostate cancer in men taking finasteride at 5 times the dose of PROPECIA. The most common side effects of PROPECIA include: decrease in sexdrive trouble getting or keepingan erectio Finasteride is a popular treatment for treating hair loss or male pattern baldness (also known as androgenetic alopecia).But does it really work and what results can you actually expect from Finasteride? In this post, The Independent Pharmacy takes a closer look to find out what you can expect when using this treatment The men in the finasteride group had a 25-percent lower risk of being diagnosed with prostate cancer — but a 68-percent higher risk of being diagnosed with high-grade disease (a Gleason score of 7 to 10; this kind of cancer is generally more difficult to cure). Since then, the authors have tried to erase these results and encourage. Finasteride Effective in Preventing Prostate Cancer. February 15, 2019. Caroline Seymour. According to the final analysis of the Prostate Cancer Prevention Trial, finasteride, an agent commonly used to treat lower urinary tract problems and baldness in men, was safe and effective in reducing the risk of prostate cancer. Ian Thompson, Jr, MD Proscar (finasteride) is prescribed to treat enlarged prostate (benign prostatic hyperplasia, BPH). Prostate gland enlargement is directly dependent on DHT (a hormone converted from the male hormone testosterone).. Proscar inhibits the enzyme necessary for the conversion of testosterone to DHT in the prostate. Proscar lowers blood and tissue DHT levels and helps reduce the size of the prostate.